Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study
dc.contributor.author | Mohrs, OK | en_US |
dc.contributor.author | Wunderlich, N | en_US |
dc.contributor.author | Petersen, SE | en_US |
dc.contributor.author | Pottmeyer, A | en_US |
dc.contributor.author | Kauczor, HU | en_US |
dc.date.accessioned | 2015-02-23T12:26:30Z | |
dc.date.available | 2011-07-04 | en_US |
dc.date.issued | 2011-07-04 | en_US |
dc.identifier.issn | 1097-6647 | en_US |
dc.identifier.other | 33 | |
dc.identifier.other | 33 | |
dc.identifier.other | 33 | |
dc.identifier.other | 33 | en_US |
dc.identifier.other | 33 | en_US |
dc.identifier.other | 33 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/6645 | |
dc.description.sponsorship | Dr. Petersen is directly funded by the Barts and the London National Institute of Health Research Cardiovascular Biomedical Research Unit | |
dc.format.extent | ? - ? | en_US |
dc.relation.ispartof | J CARDIOVASC MAGN R | en_US |
dc.subject | PATENT FORAMEN OVALE | en_US |
dc.subject | STROKE PREVENTION | en_US |
dc.subject | TRANSCATHETER OCCLUSION | en_US |
dc.subject | WARFARIN THERAPY | en_US |
dc.subject | RISK-FACTORS | en_US |
dc.subject | FIBRILLATION | en_US |
dc.subject | EXPERIENCE | en_US |
dc.subject | ANTICOAGULATION | en_US |
dc.subject | OCCLUDERS | en_US |
dc.subject | ARTIFACTS | en_US |
dc.title | Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1186/1532-429X-13-33 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 13 | en_US |
Files in this item
This item appears in the following Collection(s)
-
NIHR Advanced Imaging [387]